Comments
Loading...

Prelude Therapeutics

PRLDNASDAQ
Logo brought to you by Benzinga Data
$1.19
-0.05-4.03%
At close: -
$1.19
-0.00150-0.13%
After Hours: 3:32 PM EDT

Prelude Therapeutics (NASDAQ:PRLD) Stock Quotes, Forecast and News Summary

Prelude Therapeutics Stock (NASDAQ: PRLD) stock price, news, charts, stock research, profile.

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
1
Aug
1
2
Sep
1
Oct
1
Nov
0
0
0
0
Dec
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
2.5
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$1.22
Close$1.19
Volume / Avg.218.01K / 440.99K
Day Range$1.14 - $1.24
52 Wk Range0.80 - 6.80
Market Cap$65.41M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
33
Short Interest
18.8%
Days to Cover7.08

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
PRLD
BNR

FAQ

Q

How do I buy Prelude Therapeutics (PRLD) stock?

A

You can purchase shares of Prelude Therapeutics (NASDAQ:PRLD) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Prelude Therapeutics (PRLD) competitors?

Q

What is the forecast, or price target, for Prelude Therapeutics (PRLD) stock?

A

Prelude Therapeutics has a consensus price target of $5.50.

Q

What is the current price for Prelude Therapeutics (PRLD)?

A

The stock price for Prelude Therapeutics (NASDAQ: PRLD) is $1.1885 last updated December 24, 2024 at 3:32 PM EST.

Q

Does Prelude Therapeutics (PRLD) pay a dividend?

A

There are no upcoming dividends for Prelude Therapeutics.

Q

When is Prelude Therapeutics (NASDAQ:PRLD) reporting earnings?

A

Prelude Therapeutics’s Q4 earnings are confirmed for Thursday, February 13, 2025.

Q

Is Prelude Therapeutics (PRLD) going to split?

A

There is no upcoming split for Prelude Therapeutics.

Q

What sector and industry does Prelude Therapeutics (PRLD) operate in?

A

Prelude Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch